Evaluation with 3.0-T MR imaging: predicting the pathological response of triple-negative breast cancer treated with anthracycline and taxane neoadjuvant chemotherapy.
about
How to use magnetic resonance imaging following neoadjuvant chemotherapy in locally advanced breast cancerMagnetic Resonance Imaging after Completion of Neoadjuvant Chemotherapy Can Accurately Discriminate between No Residual Carcinoma and Residual Ductal Carcinoma In Situ in Patients with Triple-Negative Breast Cancer
P2860
Evaluation with 3.0-T MR imaging: predicting the pathological response of triple-negative breast cancer treated with anthracycline and taxane neoadjuvant chemotherapy.
description
2014 nî lūn-bûn
@nan
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
2014年论文
@zh
2014年论文
@zh-cn
name
Evaluation with 3.0-T MR imagi ...... xane neoadjuvant chemotherapy.
@en
type
label
Evaluation with 3.0-T MR imagi ...... xane neoadjuvant chemotherapy.
@en
prefLabel
Evaluation with 3.0-T MR imagi ...... xane neoadjuvant chemotherapy.
@en
P2860
P50
P356
P1433
P1476
Evaluation with 3.0-T MR imagi ...... xane neoadjuvant chemotherapy.
@en
P2093
Seung Il Kim
P2860
P304
P356
10.1177/0284185114548507
P407
P577
2014-09-16T00:00:00Z